Vaneck Etf Profile

BBH -  USA Etf  

USD 146.53  0.70  0.48%

Market Performance
0 of 100
Odds Of Distress
Over 67
Vaneck Biotech is trading at 146.53 as of the 24th of May 2022. This is a 0.48 percent increase since the beginning of the trading day. The etf's open price was 145.83. Vaneck Biotech has more than 67 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Vaneck Biotech ETF are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2022 and ending today, the 24th of May 2022. Click here to learn more.
The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Biotech is traded on NYSEArca Exchange in the United States. More on Vaneck Biotech ETF

Vaneck Biotech Etf Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Vaneck Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Vaneck Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Vaneck Biotech ETF generated a negative expected return over the last 90 days
Vaneck Biotech ETF has high likelihood to experience some financial distress in the next 2 years
The fund holds 99.85% of its assets under management (AUM) in equities
ChairmanPhilip Hornig  (View All)
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Vaneck Biotech's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
IssuerVan Eck
DescriptionVanEck Biotech ETF
Inception Date2011-12-20
BenchmarkMarket Vectors US Listed Biotech 25 Index
Entity TypeRegulated Investment Company
Asset Under Management433.67 Million
Average Trading Valume28,327.3
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionGlobal
AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianState Street Bank and Trust Company
DistributorVan Eck Securities Corporation
Portfolio ManagerHao-Hung Peter Liao, Guo Hua Jason Jin
Transfer AgentState Street Bank and Trust Company
Fiscal Year End31-Oct
ExchangeNASDAQ
Number of Constituents26.0
Market MakerVirtu Financial
Total Expense0.35
Management Fee0.35
Nav Price143.24
Two Hundred Day Average180.42
Ytd-28.82%
Average Daily Volume In Three Month21.67k
Fifty Two Week Low133.45
As Of Date11th of May 2022
Average Daily Volume Last 10 Day37.21k
Fifty Two Week High222.22
One Month-17.52%
Fifty Day Average154.71
Three Month-16.77%
Vaneck Biotech ETF [BBH] is traded in USA and was established 2011-12-20. The fund is classified under Health category within VanEck family. Vaneck Biotech ETF currently have 438.99 M in assets under management (AUM). , while the total return for the last 3 years was 4.0%.
Check Vaneck Biotech Probability Of Bankruptcy

Geographic Allocation (%)

Top Vaneck Biotech ETF Constituents

Vaneck Biotech Target Price Odds Analysis

What are Vaneck Biotech's target price odds to finish over the current price? In reference to a normal probability distribution, the odds of Vaneck Biotech jumping above the current price in 90 days from now is about 83.02%. The Vaneck Biotech ETF probability density function shows the probability of Vaneck Biotech etf to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the etf has a beta coefficient of 1.05 suggesting Vaneck Biotech ETF market returns are reactive to returns on the market. As the market goes up or down, Vaneck Biotech is expected to follow. Additionally, the company has an alpha of 0.0384, implying that it can generate a 0.0384 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 146.53HorizonTargetOdds Above 146.53
16.84%90 days
 146.53 
83.02%
Based on a normal probability distribution, the odds of Vaneck Biotech to move above the current price in 90 days from now is about 83.02 (This Vaneck Biotech ETF probability density function shows the probability of Vaneck Etf to fall within a particular range of prices over 90 days) .

Vaneck Biotech Major Institutional Holders

Institutional Holdings refers to the ownership stake in Vaneck Biotech that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vaneck Biotech's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vaneck Biotech's value.
InstituionSecurity TypeTotal SharesValue
Goldman Sachs Group IncFund Units123.5 K20 M
View Vaneck Biotech Diagnostics

Vaneck Biotech ETF Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Vaneck Biotech market risk premium is the additional return an investor will receive from holding Vaneck Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Vaneck Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Vaneck Biotech's alpha and beta are two of the key measurements used to evaluate Vaneck Biotech's performance over the market, the standard measures of volatility play an important role as well.

Vaneck Biotech ETF Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Vaneck Biotech ETF Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Vaneck Biotech price patterns.
.

Vaneck Biotech Against Markets

Picking the right benchmark for Vaneck Biotech etf is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Vaneck Biotech etf price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Vaneck Biotech is critical whether you are bullish or bearish towards Vaneck Biotech ETF at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Vaneck Biotech without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Efficient Frontier Now

   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Module

Investing Vaneck Biotech ETF

You need to understand the risk of investing before taking a position in Vaneck Biotech. The danger of trading Vaneck Biotech ETF is mainly related to its market volatility and ETF specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Vaneck Biotech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Vaneck Biotech. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Vaneck Biotech ETF is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Vaneck Biotech ETF information on this page should be used as a complementary analysis to other Vaneck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Complementary Tools for Vaneck Etf analysis

When running Vaneck Biotech ETF price analysis, check to measure Vaneck Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaneck Biotech is operating at the current time. Most of Vaneck Biotech's value examination focuses on studying past and present price action to predict the probability of Vaneck Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vaneck Biotech's price. Additionally, you may evaluate how the addition of Vaneck Biotech to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
The market value of Vaneck Biotech ETF is measured differently than its book value, which is the value of Vaneck that is recorded on the company's balance sheet. Investors also form their own opinion of Vaneck Biotech's value that differs from its market value or its book value, called intrinsic value, which is Vaneck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaneck Biotech's market value can be influenced by many factors that don't directly affect Vaneck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaneck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Vaneck Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaneck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.